CMS Administrator Compares Medicare Advantage to an Overgrown Garden

CMS Administrator Dr. Mehmet Oz told attendees at a Better Medicare Alliance event on September 22, 2026, that Medicare Advantage is a "garden" that is "vulnerable to weeds and overgrowth," according to a Healthcare Dive report. The Centers for Medicare & Medicaid Services (CMS) is the federal agency that administers Medicare, including Medicare Advantage, the privately run alternative to Original Medicare that now covers more than half of all Medicare enrollees nationwide. The Better Medicare Alliance (BMA) is an industry group representing Medicare Advantage insurers and providers, and the group hosted the event where Oz spoke.

Per Healthcare Dive's reporting, Oz's remarks suggest the Trump administration remains interested in tighter oversight of Medicare Advantage even as it has pulled back or dropped some of its earlier oversight initiatives for the program. The report as provided to us does not specify which initiatives have been scaled back or what new oversight steps, if any, CMS is planning. Medicare Plan Path has not independently verified additional details beyond what Healthcare Dive published, so this analysis treats the garden metaphor as a signal of regulatory tone rather than a confirmed rule change.

Why a Metaphor From a Lobbying Event Matters

Public remarks from a sitting CMS administrator are not the same as a proposed rule, but they often preview where an agency's attention is heading. Medicare Advantage has drawn scrutiny in recent years over risk adjustment coding, which determines how much CMS pays insurers based on enrollee health status, as well as broker marketing practices and prior authorization denial rates. When the head of CMS tells an industry audience the program needs tending, it typically points toward continued or expanded audits, marketing enforcement, or closer review of star ratings rather than a loosening of the rules.

It's also worth noting the venue. Oz made these comments to BMA, a group that lobbies on behalf of the industry it was addressing, not through a formal notice-and-comment rule or enforcement action. Any industry response or clarification was not included in the reporting available to us, so readers should treat this as an indicator of priorities heading into the next rate-setting cycle rather than a settled policy outcome.

CMS typically finalizes major Medicare Advantage payment and program rules through its annual Rate Announcement and Call Letter, usually released in the early months of the year before the plan year it governs. If Oz's comments translate into concrete action, the clearest signal would likely appear in that process for the 2027 plan year, expected in early 2027.

Key Takeaway

Fall 2026 open enrollment runs October 15 through December 7, and this is the window to compare Medicare Advantage, Medicare Supplement, and Part D options regardless of regulatory headlines. Renewed talk of Medicare Advantage oversight from CMS does not change your current 2026 plan benefits, but it's a reason to read your Annual Notice of Change (ANOC) letter closely, since insurers routinely adjust networks, formularies, and cost-sharing for the coming plan year.

What Medicare Advantage Enrollees Should Watch This Fall

Increased attention from CMS leadership on Medicare Advantage oversight has a few practical implications for people currently enrolled in a plan or weighing one for 2027:

Read your ANOC letter carefully. Insurers must send Annual Notice of Change letters by September 30 each year, detailing what's changing in premiums, provider networks, and drug coverage for the following plan year.
Expect continued scrutiny of marketing calls and mailers. CMS tightened Medicare Advantage marketing rules starting in 2022, limiting unsolicited contact and requiring clearer plan comparisons. An administrator publicly framing the program as needing oversight suggests these guardrails are unlikely to loosen.
Check your plan's star rating on Medicare.gov. CMS uses a five-star rating system to score Medicare Advantage and Part D plans on quality and member experience, and these ratings can affect a plan's bonus payments and long-term stability.
Compare options before you commit. Whether oversight tightens or not, the fundamentals of a good Medicare Advantage plan, such as provider network fit, drug formulary coverage, and total annual out-of-pocket costs, don't change. Use Medicare's Plan Finder tool or talk with a licensed, independent agent who can show you Medicare Advantage, Medigap, and Part D side by side.

This article is analysis based on Healthcare Dive's reporting of Oz's remarks, not a summary of a finalized CMS rule. Concrete changes, if they come, would most likely surface through CMS's formal rulemaking process rather than a single speech, so readers should watch for official CMS announcements ahead of the 2027 plan year rather than acting on the metaphor alone.